Results 91 to 100 of about 34,898 (217)
Clinical Obesity, Volume 15, Issue 2, April 2025.Summary This study examined the change in weight at 6 months of naltrexone/bupropion (NB), a combination pharmacological therapy for weight management, in real‐world practice in Canada. The study was conducted through an observational, retrospective, single‐arm chart review of adult patients who attended the Wharton Medical Clinic in Ontario, Canada ...
Sean Wharton +4 more
wiley +1 more source
Diabetic Medicine, EarlyView.Abstract Aims Patient activation is associated with disease self‐management; limited research has examined the role of perceived stigmatisation in this relationship. We explored links between diabetes and weight stigma, internalised weight stigma, and patient activation among people with type 2 diabetes (T2D).
Tracy J. Sims +3 more
wiley +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims The risk of diabetic nephropathy among patients with type 2 diabetes (T2D) can be reduced through optimal glycaemic control. It is not known if the pharmacological properties of long‐acting insulin analogues may reduce the risk of diabetic complications compared with neutral protamine Hagedorn (NPH) insulin.
Julia Brillinger +6 more
wiley +1 more source
Methods in pharmacoepidemiology
Therapies, 2019 Pharmacoepidemiology is the study of interactions between drugs and human populations, investigating, in real conditions of life, benefits, risks and use of drugs. Pharmacoepidemiology applies to drugs and their pharmacological evaluations, the different methods also used in epidemiology to assess in real conditions of life, benefits, risks and use of ...
Agnès, Sommet, Antoine, Pariente
openaire +3 more sources
PharmacoepidemiologyBackground: Adherence to tyrosine kinase inhibitors (TKIs), the first-line treatment for renal cell carcinoma (RCC), is critical to ensure intended treatment outcomes.
Fiona Angus +4 more
doaj +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Background Older adults with type 2 diabetes (T2DM) are less likely to receive sodium–glucose cotransporter‐2 (SGLT2) inhibitors, despite their proven cardio‐renal benefits and safety. Whether this age‐related gap is driven by frailty, sex, or other factors remains unclear.
Changyuan Yang +6 more
wiley +1 more source
Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics [PDF]
, 2016 Drug-drug interactions causing severe hypoglycemia due to antidiabetic drugs is a major clinical and public health problem. We assessed whether sulfonylurea use with a statin or fibrate was associated with severe hypoglycemia. We conducted cohort studies
Bilker, Warren B. +8 more
core +1 more source
Pharmacoepidemiology of statins
Therapies, 2019 The evaluation of the real-life benefits and risks of statins in population is a major pharmacoepidemiological issue, given their widespread use for cardiovascular prevention. The purpose of this review was not to be exhaustive but to show the contributions of pharmacoepidemiology for various aspects of the evaluation of statins such as real-life drug ...
Julien, Bezin, Nicholas, Moore
openaire +3 more sources
European Journal of Haematology, EarlyView.Assessment of the comparative effectiveness and safety of three PI‐Rd triplets in relapsed/refractory multiple myeloma using data from the global, non‐interventional, observational INSIGHT‐MM study. ABSTRACT Objectives To assess the effectiveness/safety of three proteasome inhibitors (PIs), plus lenalidomide‐dexamethasone (Rd) triplet regimens, for the
Noemi Puig +18 more
wiley +1 more source
Effects of intervention with the SAFE strategy on trachoma across Ethiopia.
, 2011 BACKGROUND/AIMS: The impact of the SAFE strategy (surgery, antibiotics, face washing, environmental hygiene), recommended to eliminate blinding trachoma, is not well explored.
Patel, D +3 more
core +1 more source